Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy.
Jihye KimJong-Pil ImJae-Joon YimChang Kyun LeeDong Il ParkChang Soo EunSung-Ae JungJeong Eun ShinKang-Moon LeeJae Hee CheonPublished in: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2020)
The rate of extrapulmonary involvement, side effects of anti-TB medications, and clinical outcomes did not differ between the IBD patients who initially developed TB during anti-TNF therapy and non-IBD patients with TB. On the other hand, the IBD patients had a lower rate of AFB smear positivity and a higher proportion of non-respiratory symptoms.